A
Alnylam Pharmaceuticals, Inc. (ALNY)
NMS – Real Time Price. Currency in USD
317.36
-10.80 (-3.29%)
At close: Mar 27, 2026, 4:00 PM EDT
315.49
-1.87 (-0.59%)
After-hours: Mar 27, 2026, 7:01 PM EDT

NMS – Real Time Price. Currency in USD
317.36
-10.80 (-3.29%)
At close: Mar 27, 2026, 4:00 PM EDT
315.49
-1.87 (-0.59%)
After-hours: Mar 27, 2026, 7:01 PM EDT
This stock has a consensus price target of $459.78 based on the ratings of 32 analysts. The high is $583.00 and the low is $298.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 298 | $ 459.78 | $ 583 |
| Change | -6.10% | 44.88% | 83.70% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-03-25 | 33.92% | Chardan Capital | $425 → $425 | Maintains | Buy |
| 2026-03-25 | 60.7% | HC Wainwright & Co. | $510 → $510 | Reiterates | Buy |
| 2026-03-16 | 3.98% | Jefferies | $522 → $330 | Downgrades | Buy → Hold |
| 2026-02-18 | 60.7% | HC Wainwright & Co. | $510 → $510 | Reiterates | Buy |
| 2026-02-17 | 29.19% | Freedom Capital Markets | $470 → $410 | Upgrades | Hold → Buy |